These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29018080)

  • 21. CBFB-MYH11 hinders early T-cell development and induces massive cell death in the thymus.
    Zhao L; Cannons JL; Anderson S; Kirby M; Xu L; Castilla LH; Schwartzberg PL; Bosselut R; Liu PP
    Blood; 2007 Apr; 109(8):3432-40. PubMed ID: 17185462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia.
    Castilla LH; Perrat P; Martinez NJ; Landrette SF; Keys R; Oikemus S; Flanegan J; Heilman S; Garrett L; Dutra A; Anderson S; Pihan GA; Wolff L; Liu PP
    Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4924-9. PubMed ID: 15044690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL1RL1 is dynamically expressed on Cbfb-MYH11
    Wang Y; Richter L; Becker M; Amador C; Hyde RK
    Sci Rep; 2019 Feb; 9(1):1729. PubMed ID: 30742053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human CD34+ cells expressing the inv(16) fusion protein exhibit a myelomonocytic phenotype with greatly enhanced proliferative ability.
    Wunderlich M; Krejci O; Wei J; Mulloy JC
    Blood; 2006 Sep; 108(5):1690-7. PubMed ID: 16670269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Basis and Targeted Inhibition of CBFβ-SMMHC Acute Myeloid Leukemia.
    Castilla LH; Bushweller JH
    Adv Exp Med Biol; 2017; 962():229-244. PubMed ID: 28299661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular basis for a dominant inactivation of RUNX1/AML1 by the leukemogenic inversion 16 chimera.
    Huang G; Shigesada K; Wee HJ; Liu PP; Osato M; Ito Y
    Blood; 2004 Apr; 103(8):3200-7. PubMed ID: 15070703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exome sequencing identifies recurring FLT3 N676K mutations in core-binding factor leukemia.
    Opatz S; Polzer H; Herold T; Konstandin NP; Ksienzyk B; Zellmeier E; Vosberg S; Graf A; Krebs S; Blum H; Hopfner KP; Kakadia PM; Schneider S; Dufour A; Braess J; Sauerland MC; Berdel WE; Büchner T; Woermann BJ; Hiddemann W; Spiekermann K; Bohlander SK; Greif PA
    Blood; 2013 Sep; 122(10):1761-9. PubMed ID: 23878140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia.
    Biernacki MA; Foster KA; Woodward KB; Coon ME; Cummings C; Cunningham TM; Dossa RG; Brault M; Stokke J; Olsen TM; Gardner K; Estey E; Meshinchi S; Rongvaux A; Bleakley M
    J Clin Invest; 2020 Oct; 130(10):5127-5141. PubMed ID: 32831296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16).
    Helbling D; Mueller BU; Timchenko NA; Schardt J; Eyer M; Betts DR; Jotterand M; Meyer-Monard S; Fey MF; Pabst T
    Blood; 2005 Aug; 106(4):1369-75. PubMed ID: 15855281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11.
    Castilla LH; Wijmenga C; Wang Q; Stacy T; Speck NA; Eckhaus M; Marín-Padilla M; Collins FS; Wynshaw-Boris A; Liu PP
    Cell; 1996 Nov; 87(4):687-96. PubMed ID: 8929537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Runx2 induces acute myeloid leukemia in cooperation with Cbfbeta-SMMHC in mice.
    Kuo YH; Zaidi SK; Gornostaeva S; Komori T; Stein GS; Castilla LH
    Blood; 2009 Apr; 113(14):3323-32. PubMed ID: 19179305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the chimeric protein product of the CBFB-MYH11 fusion gene in inv(16) leukemia cells.
    Liu PP; Wijmenga C; Hajra A; Blake TB; Kelley CA; Adelstein RS; Bagg A; Rector J; Cotelingam J; Willman CL; Collins FS
    Genes Chromosomes Cancer; 1996 Jun; 16(2):77-87. PubMed ID: 8818654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Core binding factor genes and human leukemia.
    Hart SM; Foroni L
    Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The C-terminus of CBFβ-SMMHC is required to induce embryonic hematopoietic defects and leukemogenesis.
    Kamikubo Y; Hyde RK; Zhao L; Alemu L; Rivas C; Garrett LJ; Liu PP
    Blood; 2013 Jan; 121(4):638-42. PubMed ID: 23152542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strikingly different molecular relapse kinetics in NPM1c, PML-RARA, RUNX1-RUNX1T1, and CBFB-MYH11 acute myeloid leukemias.
    Ommen HB; Schnittger S; Jovanovic JV; Ommen IB; Hasle H; Østergaard M; Grimwade D; Hokland P
    Blood; 2010 Jan; 115(2):198-205. PubMed ID: 19901261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CBFβ-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia.
    Pulikkan JA; Hegde M; Ahmad HM; Belaghzal H; Illendula A; Yu J; O'Hagan K; Ou J; Muller-Tidow C; Wolfe SA; Zhu LJ; Dekker J; Bushweller JH; Castilla LH
    Cell; 2018 Jun; 174(1):172-186.e21. PubMed ID: 29958106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Truncated RUNX1 Generated by the Fusion of RUNX1 to Antisense GRIK2 via a Cryptic Chromosome Translocation Enhances Sensitivity to Granulocyte Colony-Stimulating Factor.
    Abe A; Yamamoto Y; Katsumi A; Yamamoto H; Okamoto A; Inaguma Y; Iriyama C; Tokuda M; Okamoto M; Emi N; Tomita A
    Cytogenet Genome Res; 2020; 160(5):255-263. PubMed ID: 32544910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization of 16p deletions associated with inversion 16 defines the critical fusion for leukemogenesis.
    Marlton P; Claxton DF; Liu P; Estey EH; Beran M; LeBeau M; Testa JR; Collins FS; Rowley JD; Siciliano MJ
    Blood; 1995 Feb; 85(3):772-9. PubMed ID: 7833479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting binding partners of the CBFβ-SMMHC fusion protein for the treatment of inversion 16 acute myeloid leukemia.
    Richter L; Wang Y; Hyde RK
    Oncotarget; 2016 Oct; 7(40):66255-66266. PubMed ID: 27542261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukemogenic potency of the novel FLT3-N676K mutant.
    Huang K; Yang M; Pan Z; Heidel FH; Scherr M; Eder M; Fischer T; Büsche G; Welte K; von Neuhoff N; Ganser A; Li Z
    Ann Hematol; 2016 Apr; 95(5):783-91. PubMed ID: 26891877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.